Hui-Yen Chuang - Publications

Affiliations: 
2016-2018 Radiology Stanford University, Palo Alto, CA 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Shih KC, Chan HW, Wu CY, Chuang HY. Curcumin Enhances the Abscopal Effect in Mice with Colorectal Cancer by Acting as an Immunomodulator. Pharmaceutics. 15. PMID 37242761 DOI: 10.3390/pharmaceutics15051519  0.398
2022 Shueng PW, Shih KC, Gambhir SS, Kuo DY, Chuang HY. Cancer Detection Using an Artificial Secretable MicroRNA Found in Blood and Urine. Biomedicines. 10. PMID 35327423 DOI: 10.3390/biomedicines10030621  0.445
2021 Robinson ER, Gowrishankar G, D'Souza A, Kheirolomoom A, Haywood T, Hori SS, Chuang HY, Zeng Y, Tumbale S, Aalipour A, Beinat C, Alam IS, Sathirachinda A, Kanada M, Paulmurugan R, et al. Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34029631 DOI: 10.1016/j.jconrel.2021.05.026  0.733
2021 Tyan YS, Lee YP, Chuang HY, Wang WH, Hwang JJ. Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model. Bioscience Reports. PMID 33974005 DOI: 10.1042/BSR20204203  0.512
2019 Chuang HY, Lee YP, Lin WC, Lin YH, Hwang JJ. Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway. Scientific Reports. 9: 13284. PMID 31527721 DOI: 10.1038/S41598-019-49486-2  0.456
2019 Aalipour A, Chuang HY, Murty S, D'Souza AL, Park SM, Gulati GS, Patel CB, Beinat C, Simonetta F, Martinić I, Gowrishankar G, Robinson ER, Aalipour E, Zhian Z, Gambhir SS. Engineered immune cells as highly sensitive cancer diagnostics. Nature Biotechnology. PMID 30886438 DOI: 10.1038/S41587-019-0064-8  0.753
2017 Lee JR, Chan CT, Ruderman D, Chuang HY, Gaster RS, Atallah M, Mallick P, Lowe SW, Gambhir SS, Wang SX. Longitudinal monitoring of antibody responses against tumor cells using magneto-nanosensors with a nanoliter of blood. Nano Letters. PMID 28990786 DOI: 10.1021/Acs.Nanolett.7B02591  0.744
2017 Ronald JA, Kim BS, Gowrishankar G, Namavari M, Alam IS, D'Souza A, Nishikii H, Chuang HY, Ilovich O, Lin CF, Reeves R, Shuhendler A, Hoehne A, Chan CT, Baker J, et al. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Research. 77: 2893-2902. PMID 28572504 DOI: 10.1158/0008-5472.Can-16-2953  0.644
2016 Ronald JA, D'Souza AL, Chuang HY, Gambhir SS. Artificial MicroRNAs as Novel Secreted Reporters for Cell Monitoring in Living Subjects. Plos One. 11: e0159369. PMID 27442530 DOI: 10.1371/Journal.Pone.0159369  0.697
2016 Wang WH, Chuang HY, Chen CH, Chen WK, Hwang JJ. Lupeol acetate ameliorates collagen-induced arthritis and osteoclastogenesis of mice through improvement of microenvironment. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 79: 231-40. PMID 27044833 DOI: 10.1016/J.Biopha.2016.02.010  0.328
2015 Hsu FT, Chen TC, Chuang HY, Chang YF, Hwang JJ. Enhancement of adoptive T Cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice. Oncotarget. PMID 26683520 DOI: 10.18632/oncotarget.6628  0.738
2015 Ronald JA, Chuang HY, Dragulescu-Andrasi A, Hori SS, Gambhir SS. Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker. Proceedings of the National Academy of Sciences of the United States of America. 112: 3068-73. PMID 25713388 DOI: 10.1073/Pnas.1414156112  0.732
2014 Chuang HY, Chang YF, Liu RS, Hwang JJ. Serial low doses of sorafenib enhance therapeutic efficacy of adoptive T cell therapy in a murine model by improving tumor microenvironment Plos One. 9. PMID 25333973 DOI: 10.1371/Journal.Pone.0109992  0.771
2014 Hwang J, Chuang H, Chang Y. Abstract 1099: Sorafenib increases numbers and functions of tumor-infiltrated T cells and enhances therapeutic outcomes of adoptive T cell therapy by modifying tumor microenvironment Cancer Research. 74: 1099-1099. DOI: 10.1158/1538-7445.Am2014-1099  0.785
2013 Ronald JA, Cusso L, Chuang HY, Yan X, Dragulescu-Andrasi A, Gambhir SS. Development and validation of non-integrative, self-limited, and replicating minicircles for safe reporter gene imaging of cell-based therapies. Plos One. 8: e73138. PMID 24015294 DOI: 10.1371/Journal.Pone.0073138  0.762
2012 Chang YF, Chuang HY, Hsu CH, Liu RS, Gambhir SS, Hwang JJ. Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice. Cancer Prevention Research (Philadelphia, Pa.). 5: 444-52. PMID 22135043 DOI: 10.1158/1940-6207.Capr-11-0308  0.791
2011 Chuang HY, Chang YF, Hwang JJ. Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 65: 286-92. PMID 21723078 DOI: 10.1016/J.Biopha.2011.02.016  0.72
Show low-probability matches.